Sareum Holdings Plc - Company Profile

Powered by

All the sales intelligence you need on Sareum Holdings Plc in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Sareum Holdings Plc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Sareum Holdings Plc.

Back to companies

Sareum Holdings Plc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

The following section provides information on Sareum Holdings Plc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Sareum Holdings Plc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Stephen Barry Parker

Chairman Executive Board Since: 2016 Age: 68

Dr. Stephen Barry Parker has been the Chairman of the company since 2016. Prior to this, he served as a Partner at Celtic Pharma. Previously, he served as the Chief Financial Officer at Oxford GlycoSciences. Dr. Parker also served as the Chairman of Silence Therapeutics plc.

Read Hide full bio of Stephen Barry Parker

Timothy John Mitchell, Ph.D.

Director; Chief Operating Officer Executive Board Since: 2004 Age: 66

Dr. Timothy John Mitchell has been the Director and Chief Operating Officer of the company since 2004. Prior to this, he served as the Director of computational chemistry at Cambridge Discovery Chemistry Ltd and a Team Leader in the Computational and Structural Sciences department at SmithKline Beecham Pharmaceuticals.

Read Hide full bio of Timothy John Mitchell, Ph.D.

John Reader, Ph.D.

Chief Scientific Officer; Director Executive Board Since: 2004 Age: 59

Dr. John Reader has been the Director and Chief Scientific Officer of the company since 2004. Prior to this, he served as an Associate Director of Chemical Technologies at Millennium Pharmaceuticals Research and Development Limited. Previously, he worked with Pharmacopeia Inc and Cambridge Discovery Chemistry in the provision of high-throughput chemistry services to external and internal clients.

Read Hide full bio of John Reader, Ph.D.

Clive Birch

Secretary; Director Executive Board Since: 2022 Age: 73

Michael Owen, Ph.D.

Director Non Executive Board Since: 2018 Age: 75
Gain a 360-degree view of Sareum Holdings Plc and make more informed decisions for your business Gain a 360-degree view of Sareum Holdings Plc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer